SoFDA: an integrated web platform from syndrome ontology to network-based evaluation of disease–syndrome–formula associations for precision medicine
- 18 March 2022
- journal article
- editorial
- Published by Elsevier in Science Bulletin
- Vol. 67 (11) , 1097-1101
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81830111, 82030122, 82174533, 81774201)
- National Key Research and Development Program of China (2018YFC1705201)
This publication has 10 references indexed in Scilit:
- Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialPhytomedicine, 2021
- How COVID-19 disrupts glycometabolic controlNature Reviews Endocrinology, 2021
- Role of Toll‐like receptors in the pathogenesis of COVID‐19Journal of Medical Virology, 2021
- Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2–induced systemic toxicityJCI Insight, 2021
- Integrated network analysis of symptom clusters across disease conditionsJournal of Biomedical Informatics, 2020
- Proteomic and Metabolomic Characterization of COVID-19 Patient SeraCell, 2020
- Relationship Between Traditional Chinese Medicine(TCM)Constitution and TCM Syndrome in the Diagnosis and Treatment of Chronic DiseasesChinese Medical Sciences Journal, 2018
- A New Initiative on Precision MedicineNew England Journal of Medicine, 2015
- Human symptoms–disease networkNature Communications, 2014
- Using networks to measure similarity between genes: association index selectionNature Methods, 2013